Project Grant K99CA297018
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$171K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This federal Project Grant award of $389,988, awarded by the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower), supports research to investigate the role of tRNA modifications in glioblastoma (GBM) stem cell maintenance and tumor growth. The primary awardee, the University of Pittsburgh, will use mass spectrometry and ribosome profiling techniques to study how altered tRNA modifications influence the translational landscape in GBM stem cells. The goal is to provide molecular...
The federal Project Grant award K38CA292995, totaling $201,172.00, was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program. The award to Duke University aims to leverage cell-free DNA (cfDNA) methylation profiling as a non-invasive biomarker to improve the understanding of glioblastoma tumor biology and clinical outcomes for patients. The research will explore how changes in cfDNA methylation patterns can be used to overcome limitations...
This Project Grant award of $1,158,000 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports research at Stanford University focused on understanding and engineering cellular recognition and multicellular organization for cancer immunotherapy applications. The research aims to advance the use of engineered T cells for targeting solid tumors by exploring mechanisms to enhance T cell specificity and...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) will support research at The Leland Stanford Junior University to elucidate how microbial microproteins modulate macrophage function, a critical component of the tumor immune response. The $640,522 award, commencing on May 1, 2025 and running through April 30, 2030, will fund a multi-pronged effort to: 1) determine the molecular mechanisms by which two specific microbial proteins regulate...
This Project Grant award from the National Cancer Institute's Cancer Research Manpower Federal Grant Program (CFDA 93.398) provides $581,157 to The Leland Stanford Junior University (Stanford University) to develop and characterize a position-sensitive endcap detector for simultaneous multi-tracer positron emission tomography (PET) imaging. The project aims to enable imaging of multiple biological processes associated with neurological disorders, such as Alzheimer's disease, by detecting both...
This National Institute of Neurological Disorders and Stroke (NINDS) Project Grant award under CFDA 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders, provides $227,590 to Yale University from June 1, 2024 to July 31, 2026 to conduct research on the genetic and epigenetic mechanisms underlying glioblastoma (GBM) invasion and their therapeutic implications. The key objectives are to: Perform spatial single-cell RNA sequencing and spatial ATAC sequencing on GBM...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to understand the structural basis and complex signaling behaviors of G protein-coupled receptors (GPCRs). The $627,837 award to The Leland Stanford Junior University aims to characterize the conformational dynamics and pathway-selective (biased) signaling of GPCRs using...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $135,594 to The Leland Stanford Junior University to develop novel pharmacological approaches to rewire oncogenic gene expression and induce apoptosis in cancer cells. The key objectives are to: Develop small molecule chemical inducers of proximity (CIPs) that can kill aggressive leukemias driven by mixed-lineage-leukemia (MLL) gene translocations. This will involve organic...
The National Cancer Institute (NCI) awarded a $954,000 Project Grant (CFDA 93.396 - Cancer Biology Research) to the University of Pittsburgh to conduct research targeting glioblastoma stem cells. The research aims to leverage insights from aging in the nervous system and the molecular circuitry of cancer stem cells to understand how aging promotes tumor growth through cell autonomous mechanisms and interactions with the microenvironment. The project will leverage spatial transcriptomics and...
The National Cancer Institute (NCI) awarded a $148,568 Project Grant under its Cancer Research Manpower (CFDA 93.398) program to The Leland Stanford Junior University. The grant, titled "INTEGRATING HIGHLY MULTIPLEXED IMMUNOFLUORESCENCE WITH LABEL-FREE 2D HYPERSPECTRAL CHEMICAL IMAGING TO INTERROGATE THE COLORECTAL CANCER TUMOR-INVASIVE FRONT," will be used to fund innovative research aimed at understanding cancer mechanisms, developing new diagnostic and treatment approaches, and...